3 Results for "

coagulopathy

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "coagulopathy" in MCE Product Catalog:

Cat. No.: HY-172316
CAS No.: 2915316-40-2
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

BAY 3389934 is a selective dual inhibitor of factor IIa and factor Xa, with an IC50 of 4.9 nM for factor IIa and an IC50 of 0.66 nM for factor Xa. BAY 3389934 directly inhibits the activities of factor IIa and factor Xa and regulates the common coagulation pathway. BAY 3389934 exhibits anticoagulant and organ-protective effects. BAY 3389934 can be used in the research of sepsis and coagulopathy .
loading...
    loading...
Cat. No.: HY-173335
Target:  

Phospholipase

Research Areas:  

Infection

PLA2-IN-1 (Compound 7) is a potent and selective inhibitor of phospholipase A2 (PLA2) with an IC50 value of 1 nM PLA2-IN-1 inhibits PLA2-induced coagulopathy in vitro. PLA2-IN-1 is promising for research of snakebite envenomation caused by cobra venom .
loading...
    loading...
Cat. No.: HY-183649
CAS No.: 2270844-08-9
Research Areas:  

Cardiovascular Disease

BCN-PEG6-OH is a neutralizing agent and anticoagulant inhibitor containing strained alkyne. BCN-PEG6-OH undergoes strain-promoted alkyne-azide cycloaddition (SPAAC) click reaction with azido-Warfarin to generate an inactive product that can be rapidly cleared via the kidneys. In mice, BCN-PEG6-OH effectively reduces the anticoagulant activity of azido-Warfarin in a dose-dependent manner, normalizes prothrombin time, and exhibits no inherent anticoagulant or procoagulant effects when administered alone. BCN-PEG6-OH can be used for the research of drug-induced coagulopathy .
loading...
    loading...